Stem cell therapy for cardiovascular disease: The demise of alchemy and rise of pharmacology

British Journal of Pharmacology

Volumn 169, Issue 2, 2013, Pages 247-268

  Jadczyk, T ^a   Faulkner, A ^b   Madeddu, P ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

clinical trials; myocardial infarction; preclinical studies; regeneration; stem cells

Indexed keywords

ACUTE HEART INFARCTION; ADULT STEM CELL; CARDIOVASCULAR DISEASE; CELL HOMING; DISEASE MODEL; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; FOLLOW UP; HEART MUSCLE CELL; HUMAN; ISCHEMIC CARDIOMYOPATHY; NONHUMAN; PHARMACODYNAMICS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION;

ALCHEMY; ANIMALS; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HUMANS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84876896935     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01965.x     Document Type: Review

References (213)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al,. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989-997.
2. Aharinejad S, Abraham D, Paulus P, Zins K, Hofmann M, Michlits W, et al,. (2008). Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res 79: 395-404.
3. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, et al,. (2003). Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107: 2134-2139.
4. Alt E, Pinkernell K, Scharlau M, Coleman M, Fotuhi P, Nabzdyk C, et al,. (2010). Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. Int J Cardiol 144: 26-35.
5. Anderl JN, Robey TE, Stayton PS, Murry CE, (2009). Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res A 88: 704-710.
6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al,. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
7. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al,. (2002). Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009-3017.
8. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al,. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868.
9. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, et al,. (2005). Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112: I178-I183.
10. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al,. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
11. Blocklet D, Toungouz M, Berkenboom G, Lambermont M, Unger P, Preumont N, et al,. (2006). Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 24: 333-336.
12. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al,. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378: 1847-1857.
13. Botta R, Gao E, Stassi G, Bonci D, Pelosi E, Zwas D, et al,. (2004). Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J 18: 1392-1394.
14. Bourassa MG, Roubin GS, Detre KM, Sopko G, Krone RJ, Attabuto MJ, et al,. (1995). Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment. Am J Cardiol 75: 3C-8C.
15. Boyle AJ, Yeghiazarians Y, Shih H, Hwang J, Ye J, Sievers R, et al,. (2011). Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man. J Transl Med 9: 150.
16. Branco E, Fioretto ET, Cabral R, Palmera CA, Gregores GB, Stopiglia AJ, et al,. (2009). Myocardial homing after intrapericardial infusion of bone marrow mononuclear cells. Arq Bras Cardiol 93: e50-e53.
17. Brasselet C, Morichetti MC, Messas E, Carrion C, Bissery A, Bruneval P, et al,. (2005). Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur Heart J 26: 1551-1556.
18. Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, Koehl U, et al,. (2004). 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45: 512-518.
19. Bridges CR, Gopal K, Holt DE, Yarnall C, Cole S, Anderson RB, et al,. (2005). Efficient myocyte gene delivery with complete cardiac surgical isolation in situ. J Thorac Cardiovasc Surg 130: 1364.
20. Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, et al,. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 6: e18293.
21. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, et al,. (2008). Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299: 925-936.
22. Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Krankel N, Katare R, et al,. (2010). Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 121: 1735-1745.
23. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, et al,. (2007). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50: 1884-1893.
24. Caveliers V, De Keulenaer G, Everaert H, Van Riet I, Van Camp G, Verheye S, et al,. (2007). In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease. Q J Nucl Med Mol Imaging 51: 61-66.
25. Chacko SM, Khan M, Kuppusamy ML, Pandian RP, Varadharaj S, Selvendiran K, et al,. (2009). Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells. Am J Physiol Heart Circ Physiol 296: H1263-H1273.
26. Charwat S, Lang I, Dettke M, Graf S, Nyolczas N, Hemetsberger R, et al,. (2010). Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost 103: 564-571.
27. Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL, (2003). 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun 24: 1149-1154.
28. Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, et al,. (2011). Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9: 527-540.
29. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al,. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
30. Cui Y, Madeddu P, (2011). The role of chemokines, cytokines and adhesion molecules in stem cell trafficking and homing. Curr Pharm Des 17: 3271-3279.
31. D'Amario D, Cabral-Da-Silva MC, Zheng H, Fiorini C, Goichberg P, Steadman E, et al,. (2011). Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res 108: 1467-1481.
32. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, et al,. (2005). Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111: 442-450.
33. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R, et al,. (2005). Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 102: 3766-3771.
34. Dawn B, Tiwari S, Kucia MJ, Zuba-Surma EK, Guo Y, Sanganalmath SK, et al,. (2008). Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells 26: 1646-1655.
35. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al,. (2006). G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 20: 956-958.
36. Deten A, Volz HC, Clamors S, Leiblein S, Briest W, Marx G, et al,. (2005). Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 65: 52-63.
37. Dib N, Dinsmore J, Lababidi Z, White B, Moravec S, Campbell A, et al,. (2009). One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2: 9-16.
38. Dill T, Schachinger V, Rolf A, Mollmann S, Thiele H, Tillmanns H, et al,. (2009). Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J 157: 541-547.
39. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al,. (2003). Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844.
40. Doyle B, Kemp BJ, Chareonthaitawee P, Reed C, Schmeckpeper J, Sorajja P, et al,. (2007). Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med 48: 1708-1714.
41. Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, Vandenwijngaert S, et al,. (2010). Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 55: 2232-2243.
42. Ellison GM, Torella D, Dellegrottaglie S, Perez-Martinez C, Perez de Prado A, Vicinanza C, et al,. (2011). Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol 58: 977-986.
43. Erbs S, Linke A, Schachinger V, Assmus B, Thiele H, Diederich KW, et al,. (2007). Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 116: 366-374.
44. Fernandes S, Amirault JC, Lande G, Nguyen JM, Forest V, Bignolais O, et al,. (2006). Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res 69: 348-358.
45. Forte G, Carotenuto F, Pagliari F, Pagliari S, Cossa P, Fiaccavento R, et al,. (2008). Criticality of the biological and physical stimuli array inducing resident cardiac stem cell determination. Stem Cells 26: 2093-2103.
46. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al,. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27: 1114-1122.
47. Fujiwara M, Yan P, Otsuji TG, Narazaki G, Uosaki H, Fukushima H, et al,. (2011). Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS ONE 6: e16734.
48. Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, et al,. (2009). Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res 77: 370-376.
49. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, et al,. (2005). Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol 25: 692-697.
50. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI, (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169: 12-20.
51. Gonzalez A, Rota M, Nurzynska D, Misao Y, Tillmanns J, Ojaimi C, et al,. (2008). Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 102: 597-606.
52. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, et al,. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
53. Grajek S, Popiel M, Gil L, Breborowicz P, Lesiak M, Czepczynski R, et al,. (2010). Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J 31: 691-702.
54. Grogaard HK, Sigurjonsson OE, Brekke M, Klow NE, Landsverk KS, Lyberg T, et al,. (2007). Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion. Cardiovasc Revasc Med 8: 21-27.
55. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ, (2002). Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 55: 392-397.
56. Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K, et al,. (2010). Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 10: 98.
57. Gyongyosi M, Lang I, Dettke M, Beran G, Graf S, Sochor H, et al,. (2009). Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med 6: 70-81.
58. Gyongyosi M, Posa A, Pavo N, Hemetsberger R, Kvakan H, Steiner-Boker S, et al,. (2010). Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost 104: 376-384.
59. Haider HKH, Jiang S, Idris NM, Ashraf M, (2008). IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103: 1300-1308.
60. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al,. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54: 2277-2286.
61. Healy L, Young L, Stacey GN, (2011). Stem cell banks: preserving cell lines, maintaining genetic integrity, and advancing research. Methods Mol Biol 767: 15-27.
62. Herity NA, Lo ST, Oei F, Lee DP, Ward MR, Filardo SD, et al,. (2000). Selective regional myocardial infiltration by the percutaneous coronary venous route: a novel technique for local drug delivery. Catheter Cardiovasc Interv 51: 358-363.
63. Hermans JJ, van Essen H, Struijker-Boudier HA, Johnson RM, Theeuwes F, Smits JF, (2002). Pharmacokinetic advantage of intrapericardially applied substances in the rat. J Pharmacol Exp Ther 301: 672-678.
64. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al,. (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
65. Horackova M, Arora R, Chen R, Armour JA, Cattini PA, Livingston R, et al,. (2004). Cell transplantation for treatment of acute myocardial infarction: unique capacity for repair by skeletal muscle satellite cells. Am J Physiol Heart Circ Physiol 287: H1599-H1608.
66. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, et al,. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112: I150-I156.
67. Huang XP, Sun Z, Miyagi Y, McDonald Kinkaid H, Zhang L, Weisel RD, et al,. (2010). Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122: 2419-2429.
68. Hudson W, Collins MC, deFreitas D, Sun YS, Muller-Borer B, Kypson AP, (2007). Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation. J Surg Res 142: 263-267.
69. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, et al,. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471: 58-62.
70. Imanishi Y, Saito A, Komoda H, Kitagawa-Sakakida S, Miyagawa S, Kondoh H, et al,. (2008). Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 44: 662-671.
71. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al,. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402.
72. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, et al,. (2001). Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920-1927.
73. Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, Ii M, et al,. (2009). Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119: 699-708.
74. Jeong JO, Han JW, Kim JM, Cho HJ, Park C, Lee N, et al,. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res 108: 1340-1347.
75. Jiang M, Wang B, Wang C, He B, Fan H, Shao Q, et al,. (2008). In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis). Int J Biochem Cell Biol 40: 2284-2295.
76. Jiang M, He B, Zhang Q, Ge H, Zang MH, Han ZH, et al,. (2010). Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opin Biol Ther 10: 667-680.
77. Kane NM, Meloni M, Spencer HL, Craig MA, Strehl R, Milligan G, et al,. (2010). Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 30: 1389-1397.
78. Kang S, Yang YJ, Li CJ, Gao RL, (2008). Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 19: 327-335.
79. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS, (2006). Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 47: 1295-1301.
80. Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, et al,. (2011). Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 109: 894-906.
81. Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, et al,. (2010). CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res 107: 602-614.
82. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al,. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290.
83. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al,. (2004a). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685.
84. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al,. (2004b). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
85. Klein HM, Ghodsizad A, Marktanner R, Poll L, Voelkel T, Mohammad Hasani MR, et al,. (2007). Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 10: E66-E69.
86. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al,. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436.
87. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC, (2005). Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112: I173-I177.
88. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, et al,. (2005). Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112: 1451-1461.
89. Krause K, Jaquet K, Schneider C, Haupt S, Lioznov MV, Otte KM, et al,. (2009). Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart 95: 1145-1152.
90. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, et al,. (2007). Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21: 297-303.
91. Kupatt C, Hinkel R, Lamparter M, von Bruhl ML, Pohl T, Horstkotte J, et al,. (2005). Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase. Circulation 112: I117-I122.
92. Kurpisz M, Czepczynski R, Grygielska B, Majewski M, Fiszer D, Jerzykowska O, et al,. (2007). Bone marrow stem cell imaging after intracoronary administration. Int J Cardiol 121: 194-195.
93. Kuyama J, McCormack A, George AJ, Heelan BT, Osman S, Batchelor JR, et al,. (1997). Indium-111 labelled lymphocytes: isotope distribution and cell division. Eur J Nucl Med 24: 488-496.
94. van Laake LW, Qian L, Cheng P, Huang Y, Hsiao EC, Conklin BR, et al,. (2010). Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance. Circ Res 107: 340-347.
95. Ladage D, Turnbull IC, Ishikawa K, Takewa Y, Rapti K, Morel C, et al,. (2011). Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model. Gene Ther 18: 979-985.
96. Lapidot T, Petit I, (2002). Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30: 973-981.
97. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, et al,. (2000). Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102: III56-III61.
98. Li Q, Turdi S, Thomas DP, Zhou T, Ren J, (2010). Intramyocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction. Toxicol Lett 195: 119-126.
99. Lian WS, Cheng WT, Cheng CC, Hsiao FS, Chen JJ, Cheng CF, et al,. (2011). In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice. Life Sci 88: 455-464.
100. Lin Q, Fu Q, Zhang Y, Wang H, Liu Z, Zhou J, et al,. (2010). Tumourigenesis in the infarcted rat heart is eliminated through differentiation and enrichment of the transplanted embryonic stem cells. Eur J Heart Fail 12: 1179-1185.
101. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, et al,. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50: 1761-1767.
102. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, et al,. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68-73.
103. Loffredo FS, Steinhauser ML, Gannon J, Lee RT, (2011). Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8: 389-398.
104. Love Z, Wang F, Dennis J, Awadallah A, Salem N, Lin Y, et al,. (2007). Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med 48: 2011-2020.
105. Mack GS, (2011). ReNeuron and StemCells get green light for neural stem cell trials. Nat Biotechnol 29: 95-97.
106. Madeddu P, Emanueli C, Pelosi E, Salis MB, Cerio AM, Bonanno G, et al,. (2004). Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 18: 1737-1739.
107. Maisch B, Ristic AD, Seferovic PM, Spodick DH, (2000). Intrapericardial treatment of autoreactive myocarditis with triamcinolon. Successful administration in patients with minimal pericardial effusion. Herz 25: 781-786.
108. Maisch B, Ristic AD, Rupp H, Spodick DH, (2001). Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88: 1323-1326.
109. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, et al,. (2004). Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25: 587-610.
110. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29: 1807-1818.
111. Mazhari R, Hare JM, (2007). Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4: S21-S26.
112. Meluzin J, Mayer J, Groch L, Janousek S, Hornacek I, Hlinomaz O, et al,. (2006). Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 152: 975.e9-e15.
113. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al,. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083.
114. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P, et al,. (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30: 2978-2984.
115. Mitchell AJ, Sabondjian E, Sykes J, Deans L, Zhu W, Lu X, et al,. (2010). Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. J Nucl Med 51: 413-417.
116. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, et al,. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34: 107-116.
117. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al,. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668.
118. Nelson TJ, Ge ZD, Van Orman J, Barron M, Rudy-Reil D, Hacker TA, et al,. (2006). Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A Discov Mol Cell Evol Biol 288: 1216-1224.
119. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A, (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408-416.
120. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, et al,. (2006). Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14: 840-850.
121. Norol F, Bonnet N, Peinnequin A, Chretien F, Legrand R, Isnard R, et al,. (2007). GFP-transduced CD34+ and Lin- CD34- hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct. Exp Hematol 35: 653-661.
122. Nowak B, Weber C, Schober A, Zeiffer U, Liehn EA, von Hundelshausen P, et al,. (2007). Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells. Eur J Nucl Med Mol Imaging 34: 715-721.
123. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, et al,. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21: 1345-1357.
124. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al,. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100: 12313-12318.
125. O'Malley K, Scott EW, (2004). Stem cell fusion confusion. Exp Hematol 32: 131-134.
126. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al,. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
127. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, et al,. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384.
128. Paczkowska E, Kucia M, Koziarska D, Halasa M, Safranow K, Masiuk M, et al,. (2009). Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke. Stroke 40: 1237-1244.
129. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, et al,. (2003). Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879-888.
130. Pasi CE, Dereli-Oz A, Negrini S, Friedli M, Fragola G, Lombardo A, et al,. (2011). Genomic instability in induced stem cells. Cell Death Differ 18: 745-753.
131. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC, Jr, Kormos R, et al,. (2005). Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 130: 1631-1638.
132. Penicka M, Lang O, Widimsky P, Kobylka P, Kozak T, Vanek T, et al,. (2007). One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction. Heart 93: 837-841.
133. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al,. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
134. Place ES, Evans ND, Stevens MM, (2009). Complexity in biomaterials for tissue engineering. Nat Mater 8: 457-470.
135. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, et al,. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848-855.
136. Pompilio G, Steinhoff G, Liebold A, Pesce M, Alamanni F, Capogrossi MC, et al,. (2008). Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 56: 71-76.
137. Qian H, Yang Y, Huang J, Gao R, Dou K, Yang G, et al,. (2007). Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts. J Cell Biochem 102: 64-74.
138. Qiao H, Zhang H, Zheng Y, Ponde DE, Shen D, Gao F, et al,. (2009). Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection. Radiology 250: 821-829.
139. Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, et al,. (2011). CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J 161: 98-105.
140. Ratajczak MZ, (2011). The emerging role of microvesicles in cellular therapies for organ/tissue regeneration. Nephrol Dial Transplant 26: 1453-1456.
141. Ratajczak MZ, Zuba-Surma EK, Wysoczynski M, Ratajczak J, Kucia M, (2008). Very small embryonic-like stem cells: characterization, developmental origin, and biological significance. Exp Hematol 36: 742-751.
142. Ratajczak MZ, Shin DM, Ratajczak J, Kucia M, Bartke A, (2010). A novel insight into aging: are there pluripotent very small embryonic-like stem cells (VSELs) in adult tissues overtime depleted in an Igf-1-dependent manner? Aging (Albany NY) 2: 875-883.
143. Ratajczak MZ, Liu R, Ratajczak J, Kucia M, Shin DM, (2011). The role of pluripotent embryonic-like stem cells residing in adult tissues in regeneration and longevity. Differentiation 81: 153-161.
144. Ratajczak MZ, Kim C, Wu W, Shin DM, Bryndza E, Kucia M, et al,. (2012). The role of innate immunity in trafficking of hematopoietic stem cells-an emerging link between activation of complement cascade and chemotactic gradients of bioactive sphingolipids. Adv Exp Med Biol 946: 37-54.
145. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al,. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298.
146. Reinecke H, Murry CE, (2000). Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol 9: 337-344.
147. Rong SL, Lu YX, Liao YH, Wang XL, Wang YJ, Chang C, et al,. (2008). Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats. Chin Med J (Engl) 121: 347-354.
148. Rosen AB, Kelly DJ, Schuldt AJ, Lu J, Potapova IA, Doronin SV, et al,. (2007). Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 25: 2128-2138.
149. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, Ferreira-Martins J, et al,. (2008). Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103: 107-116.
150. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, et al,. (2011). Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 109: 724-728.
151. Scarborough P, Bhatnagar P, Wickramasinghe K, Smolina K, Mitchell C, Rayner M, (2010). Coronary heart disease statistics 2010. British Heart Foundation heart statistics publications 2010 [cited 21/06/2011]; Available from: http://www.bhf.org.uk/heart-health/statistics/heart-statistics- publications.aspx
152. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al,. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699.
153. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al,. (2006a). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221.
154. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al,. (2006b). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783.
155. Schachinger V, Aicher A, Dobert N, Rover R, Diener J, Fichtlscherer S, et al,. (2008). Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118: 1425-1432.
156. Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, et al,. (2008). Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol 103: 69-77.
157. Sheikh AY, Huber BC, Narsinh KH, Spin JM, van der Bogt K, de Almeida PE, et al,. (2012). In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol 32: 92-102.
158. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, Rozwadowska N, et al,. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148: 531-537.
159. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, et al,. (2005). Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 26: 1188-1195.
160. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, et al,. (2007). Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445: 177-182.
161. Smart N, Bollini S, Dube KN, Vieira JM, Zhou B, Davidson S, et al,. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature 474: 640-644.
162. Smits AM, van Laake LW, den Ouden K, Schreurs C, Szuhai K, van Echteld CJ, et al,. (2009). Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 83: 527-535.
163. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al,. (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-2069.
164. So KH, Han YJ, Park HY, Kim JG, Sung DJ, Bae YM, et al,. (2010). Generation of functional cardiomyocytes from mouse induced pluripotent stem cells. Int J Cardiol 153: 277-285.
165. van der Spoel TI, Jansenof Lorkeers SJ, Agostoni P, van Belle E, Gyongyosi M, Sluijter JP, et al,. (2011). Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res 91: 649-658.
166. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al,. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46.
167. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, et al,. (2007). Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133: 717-725.
168. Steele A, Jones OY, Gok F, Marikar Y, Steele P, Chamizo W, et al,. (2005). Stem-like cells traffic from heart ex vivo, expand in vitro, and can be transplanted in vivo. J Heart Lung Transplant 24: 1930-1939.
169. Strauer BE, (1979). Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 44: 730-740.
170. Strauer BE, Steinhoff G, (2011). 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 58: 1095-1104.
171. Surani MA, Hayashi K, Hajkova P, (2007). Genetic and epigenetic regulators of pluripotency. Cell 128: 747-762.
172. Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, et al,. (2007). Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J Thorac Cardiovasc Surg 134: 1249-1258.
173. Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, et al,. (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 18: 1153-1155.
174. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, et al,. (2005). Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112: I166-I172.
175. Swijnenburg RJ, Govaert JA, van der Bogt KE, Pearl JI, Huang M, Stein W, et al,. (2010). Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imaging 3: 77-85.
176. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al,. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
177. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, et al,. (2010). Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121: 293-305.
178. Tang Y, Heaysman CL, Willis S, Lewis AL, (2011). Physical hydrogels with self-assembled nanostructures as drug delivery systems. Expert Opin Drug Deliv 8: 1141-1159.
179. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, et al,. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933.
180. Tendera M, Wojakowski W, Ruzyllo W, Chojnowska L, Kepka C, Tracz W, et al,. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30: 1313-1321.
181. Teng CJ, Luo J, Chiu RC, Shum-Tim D, (2006). Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 132: 628-632.
182. Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, Lamson T, et al,. (2003). Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 41: 1964-1971.
183. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al,. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
184. Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD, (2005). The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46: 1799-1802.
185. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
186. Tran TH, Wang X, Browne C, Zhang Y, Schinke M, Izumo S, et al,. (2009). Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells 27: 1869-1878.
187. Uemura R, Xu M, Ahmad N, Ashraf M, (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421.
188. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, et al,. (2005). Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673.
189. Urbich C, Dimmeler S, (2004). Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
190. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, et al,. (2008). Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118: 2057-2062.
191. Vicario J, Campos C, Piva J, Faccio F, Gerardo L, Becker C, et al,. (2004). Transcoronary sinus administration of autologous bone marrow in patients with chronic refractory stable angina Phase 1. Cardiovasc Radiat Med 5: 71-76.
192. Vicario J, Campo C, Piva J, Faccio F, Gerardo L, Becker C, et al,. (2005). One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina. Cardiovasc Revasc Med 6: 99-107.
193. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD, (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363: 783-784.
194. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, et al,. (2006). The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24: 1779-1788.
195. Wei H, Ooi TH, Tan G, Lim SY, Qian L, Wong P, et al,. (2010). Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Fail Rev 15: 1-14.
196. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, et al,. (2008). A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26: 916-924.
197. Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, et al,. (2009). Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 53: 1-9.
198. Wojakowski W, Landmesser U, Bachowski R, Jadczyk T, Tendera M, (2012). Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 26: 23-33.
199. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al,. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148.
200. Wu K, Mo X, Lu S, Han Z, (2011a). Retrograde delivery of stem cells: promising delivery strategy for myocardial regenerative therapy. Clin Transplant 25: 830-833.
201. Wu KH, Han ZC, Mo XM, Zhou B, (2011b). Cell delivery in cardiac regenerative therapy. Ageing Res Rev 11: 32-40.
202. Xi J, Khalil M, Shishechian N, Hannes T, Pfannkuche K, Liang H, et al,. (2010). Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J 24: 2739-2751.
203. Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, et al,. (2004). Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229: 623-631.
204. Ye L, Haider HKH, Tan R, Toh W, Law PK, Tan W, et al,. (2007). Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation 116: I113-I120.
205. Ye L, Haider HKH, Tan R, Su L, Law PK, Zhang W, et al,. (2008). Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials 29: 2125-2137.
206. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al,. (2007). Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
207. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al,. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
208. Yu LH, Kim MH, Park TH, Cha KS, Kim YD, Quan ML, et al,. (2010). Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. Int J Cardiol 139: 166-172.
209. Zhang P, Zhang H, Wang H, Wei Y, Hu S, (2006). Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats. Artif Organs 30: 86-93.
210. Zhang SN, Sun AJ, Ge JB, Yao K, Huang ZY, Wang KQ, et al,. (2009). Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int J Cardiol 136: 178-185.
211. Zuba-Surma EK, Wu W, Ratajczak J, Kucia M, Ratajczak MZ, (2009). Very small embryonic-like stem cells in adult tissues-potential implications for aging. Mech Ageing Dev 130: 58-66.
212. Zuba-Surma EK, Guo Y, Taher H, Sanganalmath SK, Hunt G, Vincent RJ, et al,. (2011). Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction. J Cell Mol Med 15: 1319-1328.
213. Zwi-Dantsis L, Mizrahi I, Arbel G, Gepstein A, Gepstein L, (2011). Scalable production of cardiomyocytes derived from c-Myc free induced pluripotent stem cells. Tissue Eng Part A 17: 1027-1037.